<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01428999</url>
  </required_header>
  <id_info>
    <org_study_id>BR-100-039</org_study_id>
    <nct_id>NCT01428999</nct_id>
  </id_info>
  <brief_title>Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora</brief_title>
  <official_title>Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cheng-Kung University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Science Council, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cheng-Kung University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of &quot;combined probiotics&quot; to improve the
      gastrointestinal function and intestinal bacteria flora
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Probiotics were known to improve gastrointestinal function before. This is a single-blind
      placebo control clinical study. We will perform gastrointestinal function questionnaire and
      collect stool as baseline data before the study (0-week). Then healthy subjects will be
      randomized to two groups.

      Experimental: probiotics 1 pack bid for 3 weeks. Probiotics : (AB-kefir)：Lactobacillus
      acidophilus,Bifidobacterium longum,Lactobacillus paracasei,Lactobacillus
      rhamnosus,Lactobacillus fermentum,Streptococcus thermophilus,Lactobacillus
      helveticus,Kluyveromyces fragilis. Other components include starch,oligosaccharide,yeast
      powder, superior standard spice， calcium pantothenate， VitB1， VitB12， biotin and folic acid.

      Placebo group: placebo 1 pack bid for 3 weeks. Placebo: Except the probiotics (AB-kefir),the
      other components are the same with study group.

      Then gastrointestinal function questionnaire and stool collection will be performed at the
      end of 1st, 2nd, 3rd, and 4th weeks after starting the study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of gastrointestinal function after probiotics use</measure>
    <time_frame>28 days</time_frame>
    <description>Changes of gastrointestinal function, such as constipation, abdominal distension and appetite after proiotics and placebo use.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of intestinal bacteria flora after probiotics use</measure>
    <time_frame>28 days</time_frame>
    <description>Changes of intestinal bacteria flora: (1) aerobic bacteria count (2) anaerobic bacteria count (3) Bifidobacterium count (4) Clostridium perfringens count (5) Staphylococcus aureus count (6) E. coli and K. pneumoniae count
The ratio for the antibiotics resistant bacteria ( such as Vancomycin-resistant Enterococcus，third-generation cephalosporin resistance E. coli, Methicillin-resistant Staphylococcus aureous, Extended-spectrum beta lactamase E. coli and K. pneumoniae)
Changes of the bacteria virulence factors for the intestinal E. coli and K. pneumonia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Gastrointestinal Function</condition>
  <condition>Intestinal Bacteria Flora</condition>
  <arm_group>
    <arm_group_label>probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 pack bid use for 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo 1pack bid for 3 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>probiotics</intervention_name>
    <description>probiotics 1 pack (2g) bid for three weeks</description>
    <arm_group_label>probiotics</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy people who are aged between 20 and 40 years

        Exclusion Criteria:

          -  1. People who use probiotics medication and food that can inhibit bacteria growth
             within one month before the study 2. People who have active infection 3. People who
             have active or chronic gastro-intestinal disease 4. People who have diarrhea within
             two weeks before the study 5. People who are drug or alcohol abuser 6. People who are
             poor compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming-Cheng Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cheng-Kung University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ming-Cheng Wang, MD</last_name>
    <phone>886-6-2353535</phone>
    <phone_ext>2594</phone_ext>
    <email>wangmc@mail.ncku.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>An-bang Wu, MD</last_name>
    <phone>886-6-2353535</phone>
    <phone_ext>2594</phone_ext>
    <email>anbang@mail.ncku.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Cheng Kung University Hospital</name>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming-Cheng Wang, MD</last_name>
      <phone>886-6-2353535</phone>
      <phone_ext>2594</phone_ext>
      <email>wangmc@mail.ncku.edu.tw</email>
    </contact>
    <contact_backup>
      <last_name>An-Bang Wu, MD</last_name>
      <phone>886-6-2353535</phone>
      <phone_ext>2594</phone_ext>
      <email>anbang@mail.ncku.edu.tw</email>
    </contact_backup>
    <investigator>
      <last_name>Ming-Cheng Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>An-Bang Wu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hung-Lien Wu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiunn-Jong Wu, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2011</study_first_submitted>
  <study_first_submitted_qc>September 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2011</study_first_posted>
  <last_update_submitted>September 2, 2011</last_update_submitted>
  <last_update_submitted_qc>September 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>probiotics</keyword>
  <keyword>gastrointestinal function</keyword>
  <keyword>intestinal bacteria flora</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

